BioHarvest Sciences
BHST
19 hedge funds and large institutions have $4.8M invested in BioHarvest Sciences in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.
0.11% less ownership
Funds ownership: 10.36% → 10.25% (-0.11%)
5% less funds holding
Funds holding: 20 → 19 (-1)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
35% less capital invested
Capital invested by funds: $7.38M → $4.8M (-$2.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Evercore Wealth Management
New York
|
+$293K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$180K |
| 3 |
MFG
Magnus Financial Group
New York
|
+$134K |
| 4 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
+$121K |
| 5 |
TNA
True North Advisors
Dallas,
Texas
|
+$73.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$670K |
| 2 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$86.8K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$62.7K |
| 4 |
Jane Street
New York
|
-$56.8K |
| 5 |
VA
Vident Advisory
Alpharetta,
Georgia
|
-$50.2K |
BHST Hedge Fund Activity: Q2 2026 in Review
19 of the 8,296 institutional investors tracked by Wall St. Rank reported a position in BioHarvest Sciences (BHST) for Q2 2026, worth a combined $4.8M — down 35% from $7.38M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BHST and 2 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 6 added.
The largest buyer was Evercore Wealth Management, adding an estimated $293K. The largest seller was Alyeska Investment Group, cutting an estimated $670K.
- 19 institutional investors held BioHarvest Sciences (BHST) as of Q2 2026, down from 20 in Q1 2026.
- Funds reported $4.8M of BioHarvest Sciences stock for Q2 2026, down 35% quarter-over-quarter.
- 2 funds opened new BioHarvest Sciences positions in Q2 2026 and 3 closed out, a net change of -1 holder.
- The largest BioHarvest Sciences buyer in Q2 2026 was Evercore Wealth Management, an estimated $293K added.
- The largest BioHarvest Sciences seller in Q2 2026 was Alyeska Investment Group, an estimated $670K sold.
Based on aggregated 13F filings for Q2 2026.